Thomas A. Burley

622 total citations
10 papers, 444 citations indexed

About

Thomas A. Burley is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Genetics. According to data from OpenAlex, Thomas A. Burley has authored 10 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Biomedical Engineering and 3 papers in Genetics. Recurrent topics in Thomas A. Burley's work include Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Thomas A. Burley is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Photodynamic Therapy Research Studies (3 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Thomas A. Burley collaborates with scholars based in United Kingdom, Poland and Germany. Thomas A. Burley's co-authors include Gabriela Krämer-Marek, Wojciech Szopa, Wojciech Kaspera, Kevin J. Harrington, Chiara Da Pieve, Maria Vinci, Anant Shah, Anna Mrozek‐Wilczkiewicz, Wim J.G. Oyen and Louis Allott and has published in prestigious journals such as Clinical Cancer Research, International Journal of Cancer and eLife.

In The Last Decade

Thomas A. Burley

9 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Burley United Kingdom 8 180 151 125 106 106 10 444
Sei Sai South Korea 12 203 1.1× 70 0.5× 128 1.0× 159 1.5× 84 0.8× 25 492
Maleeha Qazi Canada 8 184 1.0× 187 1.2× 122 1.0× 62 0.6× 56 0.5× 21 426
Elodie A. Pérès France 14 128 0.7× 149 1.0× 95 0.8× 102 1.0× 54 0.5× 27 462
Wojciech Szopa Poland 5 136 0.8× 151 1.0× 118 0.9× 79 0.7× 57 0.5× 8 339
Inderjit Daphu Norway 6 143 0.8× 166 1.1× 53 0.4× 82 0.8× 93 0.9× 6 398
Narasimha Kumar Karanam United States 8 158 0.9× 135 0.9× 85 0.7× 66 0.6× 108 1.0× 19 395
Tina Zheng United States 4 305 1.7× 205 1.4× 159 1.3× 75 0.7× 60 0.6× 7 626
Giulia Cerretti Italy 10 107 0.6× 281 1.9× 77 0.6× 78 0.7× 56 0.5× 30 402
Jianyi Ding United States 5 258 1.4× 254 1.7× 185 1.5× 71 0.7× 41 0.4× 6 501
Samuel A. Sprowls United States 12 178 1.0× 89 0.6× 83 0.7× 143 1.3× 107 1.0× 23 464

Countries citing papers authored by Thomas A. Burley

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Burley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Burley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Burley more than expected).

Fields of papers citing papers by Thomas A. Burley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Burley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Burley. The network helps show where Thomas A. Burley may publish in the future.

Co-authorship network of co-authors of Thomas A. Burley

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Burley. A scholar is included among the top collaborators of Thomas A. Burley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Burley. Thomas A. Burley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Burley, Thomas A., David Li, Eleni E Ladikou, et al.. (2022). Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma. Cancers. 14(6). 1489–1489. 10 indexed citations
3.
Burley, Thomas A., Andrew Hesketh, Giselda Bucca, et al.. (2022). Elucidation of Focal Adhesion Kinase as a Modulator of Migration and Invasion and as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia. Cancers. 14(7). 1600–1600. 7 indexed citations
4.
Pieve, Chiara Da, Thomas A. Burley, Anant Shah, et al.. (2020). Immunomodulatory activity of IR700-labelled affibody targeting HER2. Cell Death and Disease. 11(10). 886–886. 24 indexed citations
5.
Stowe, Cassandra, Thomas A. Burley, Maria Vinci, et al.. (2019). Near-infrared dual bioluminescence imaging in mouse models of cancer using infraluciferin. eLife. 8. 47 indexed citations
6.
Pieve, Chiara Da, Thomas A. Burley, Rhodri Smith, et al.. (2018). HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. Clinical Cancer Research. 24(8). 1853–1865. 23 indexed citations
7.
Burley, Thomas A., Chiara Da Pieve, Louis Allott, et al.. (2018). Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. Journal of Nuclear Medicine. 60(3). 353–361. 25 indexed citations
8.
Burley, Thomas A., Anant Shah, Wojciech Szopa, et al.. (2018). Near‐infrared photoimmunotherapy targeting EGFR—Shedding new light on glioblastoma treatment. International Journal of Cancer. 142(11). 2363–2374. 52 indexed citations
9.
Mrozek‐Wilczkiewicz, Anna, Katarzyna Malarz, Marzena Rams‐Baron, et al.. (2017). Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene Expression. Journal of Cancer. 8(11). 1979–1987. 15 indexed citations
10.
Szopa, Wojciech, Thomas A. Burley, Gabriela Krämer-Marek, & Wojciech Kaspera. (2017). Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. BioMed Research International. 2017. 1–13. 241 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026